Cargando…

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat. Treatment rates by race/ethnicity were 38.8% (White), 31.3% (Black/African American), 31.0% (Hispanic/Latino), and 30.1% (Asian/Pacific Islander/ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lash, Maura K., Latham, Ned H., Chan, Pui Ying, Foote, Mary M.K., Garcia, Elizabeth A., Silverstein, Matthew F., Wong, Marcia, Alexander, Mark, Alroy, Karen A., Bajaj, Lovedeep, Chen, Kuan, Howard, James Steele, Jones, Lucretia E., Lee, Ellen H., Watkins, Julian L., McPherson, Tristan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617352/
https://www.ncbi.nlm.nih.gov/pubmed/37796277
http://dx.doi.org/10.3201/eid2911.230814
_version_ 1785129592186470400
author Lash, Maura K.
Latham, Ned H.
Chan, Pui Ying
Foote, Mary M.K.
Garcia, Elizabeth A.
Silverstein, Matthew F.
Wong, Marcia
Alexander, Mark
Alroy, Karen A.
Bajaj, Lovedeep
Chen, Kuan
Howard, James Steele
Jones, Lucretia E.
Lee, Ellen H.
Watkins, Julian L.
McPherson, Tristan D.
author_facet Lash, Maura K.
Latham, Ned H.
Chan, Pui Ying
Foote, Mary M.K.
Garcia, Elizabeth A.
Silverstein, Matthew F.
Wong, Marcia
Alexander, Mark
Alroy, Karen A.
Bajaj, Lovedeep
Chen, Kuan
Howard, James Steele
Jones, Lucretia E.
Lee, Ellen H.
Watkins, Julian L.
McPherson, Tristan D.
author_sort Lash, Maura K.
collection PubMed
description We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat. Treatment rates by race/ethnicity were 38.8% (White), 31.3% (Black/African American), 31.0% (Hispanic/Latino), and 30.1% (Asian/Pacific Islander/other). Future public health emergency responses must prioritize institutional and structural racism mitigation.
format Online
Article
Text
id pubmed-10617352
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-106173522023-11-01 Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA Lash, Maura K. Latham, Ned H. Chan, Pui Ying Foote, Mary M.K. Garcia, Elizabeth A. Silverstein, Matthew F. Wong, Marcia Alexander, Mark Alroy, Karen A. Bajaj, Lovedeep Chen, Kuan Howard, James Steele Jones, Lucretia E. Lee, Ellen H. Watkins, Julian L. McPherson, Tristan D. Emerg Infect Dis Dispatch We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat. Treatment rates by race/ethnicity were 38.8% (White), 31.3% (Black/African American), 31.0% (Hispanic/Latino), and 30.1% (Asian/Pacific Islander/other). Future public health emergency responses must prioritize institutional and structural racism mitigation. Centers for Disease Control and Prevention 2023-11 /pmc/articles/PMC10617352/ /pubmed/37796277 http://dx.doi.org/10.3201/eid2911.230814 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Lash, Maura K.
Latham, Ned H.
Chan, Pui Ying
Foote, Mary M.K.
Garcia, Elizabeth A.
Silverstein, Matthew F.
Wong, Marcia
Alexander, Mark
Alroy, Karen A.
Bajaj, Lovedeep
Chen, Kuan
Howard, James Steele
Jones, Lucretia E.
Lee, Ellen H.
Watkins, Julian L.
McPherson, Tristan D.
Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
title Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
title_full Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
title_fullStr Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
title_full_unstemmed Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
title_short Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
title_sort racial and socioeconomic equity of tecovirimat treatment during the 2022 mpox emergency, new york, new york, usa
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617352/
https://www.ncbi.nlm.nih.gov/pubmed/37796277
http://dx.doi.org/10.3201/eid2911.230814
work_keys_str_mv AT lashmaurak racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT lathamnedh racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT chanpuiying racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT footemarymk racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT garciaelizabetha racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT silversteinmatthewf racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT wongmarcia racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT alexandermark racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT alroykarena racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT bajajlovedeep racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT chenkuan racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT howardjamessteele racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT joneslucretiae racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT leeellenh racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT watkinsjulianl racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa
AT mcphersontristand racialandsocioeconomicequityoftecovirimattreatmentduringthe2022mpoxemergencynewyorknewyorkusa